Table 5 The screening process for anti-inflammatory activity of the test pigments using inhibition of albumin denaturation assay
The test compound | Concentration µg/ml | Absorption at 550 nm Wavelength | Inhibition of protein denaturation (%) |
|---|---|---|---|
Pigment extract solution | 10 | 0.991 | ND |
20 | 0.980 | ND | |
30 | 0.898 | ND | |
40 | 0.851 | ND | |
50 | 0.801 | ND | |
60 | 0.786 | 4.1 ± 13 | |
70 | 0.733 | 10.6 ± 15 | |
80 | 0.621 | 24.2 ± 12 | |
90 | 0.530 | 35.36 ± 11 | |
100 | 0.490 | 40 ± 12 | |
200 | 0.115 | 85.9 ± 13 | |
Diclofenac sodium | 200 | 0.075 | 90 ± 9 |